Shengjun Fan

603 total citations
19 papers, 493 citations indexed

About

Shengjun Fan is a scholar working on Molecular Biology, Epidemiology and Cell Biology. According to data from OpenAlex, Shengjun Fan has authored 19 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Cell Biology. Recurrent topics in Shengjun Fan's work include Autophagy in Disease and Therapy (5 papers), Curcumin's Biomedical Applications (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Shengjun Fan is often cited by papers focused on Autophagy in Disease and Therapy (5 papers), Curcumin's Biomedical Applications (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Shengjun Fan collaborates with scholars based in China and United States. Shengjun Fan's co-authors include Lu Tie, Xuejun Li, Yan Pan, Yilixiati Xiaokaiti, Yu An, Xin Li, Haopeng Yang, Yubin Kang, Xuejun Li and Nelson J. Chao and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Molecular Pharmacology.

In The Last Decade

Shengjun Fan

19 papers receiving 484 citations

Peers

Shengjun Fan
Rut Klinger Ireland
Jasmin Shafarin United Arab Emirates
Ajay Palagani United States
Yuyu Zhu China
Hao Feng China
Shengjun Fan
Citations per year, relative to Shengjun Fan Shengjun Fan (= 1×) peers Sebastian Maxeiner

Countries citing papers authored by Shengjun Fan

Since Specialization
Citations

This map shows the geographic impact of Shengjun Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengjun Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengjun Fan more than expected).

Fields of papers citing papers by Shengjun Fan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengjun Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengjun Fan. The network helps show where Shengjun Fan may publish in the future.

Co-authorship network of co-authors of Shengjun Fan

This figure shows the co-authorship network connecting the top 25 collaborators of Shengjun Fan. A scholar is included among the top collaborators of Shengjun Fan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengjun Fan. Shengjun Fan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wu, Jian, et al.. (2023). Inhibition of Sphingosine Kinase 2 Results in PARK2-Mediated Mitophagy and Induces Apoptosis in Multiple Myeloma. Current Oncology. 30(3). 3047–3063. 4 indexed citations
2.
Kang, Yubin, Pasupathi Sundaramoorthy, Cristina Gasparetto, et al.. (2022). Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma. Annals of Hematology. 102(2). 369–383. 11 indexed citations
3.
Fan, Shengjun, Qian Liu, Yao He, et al.. (2021). A novel risk score predicts prognosis in melanoma: The combination of three tumor-infiltrating immune cells and four immune-related genes. Clinical Immunology. 228. 108751–108751. 3 indexed citations
4.
Fan, Shengjun, Trevor Price, Wei Huang, et al.. (2020). PINK1‐Dependent Mitophagy Regulates the Migration and Homing of Multiple Myeloma Cells via the MOB1B‐Mediated Hippo‐YAP/TAZ Pathway. Advanced Science. 7(5). 1900860–1900860. 38 indexed citations
5.
Fan, Shengjun, Xin Li, Yilixiati Xiaokaiti, et al.. (2019). The novel small molecular BH3 mimetics SM3 and its regulation of cell apoptosis and autophagy. Biochemical and Biophysical Research Communications. 517(1). 15–22. 3 indexed citations
6.
Shi, Yundi, Shengjun Fan, Di Wang, et al.. (2018). FOXO1 inhibition potentiates endothelial angiogenic functions in diabetes via suppression of ROCK1/Drp1-mediated mitochondrial fission. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(7). 2481–2494. 52 indexed citations
7.
Fan, Shengjun, Jing Zheng, Wei Huang, et al.. (2018). Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myeloma. Journal of Hematology & Oncology. 11(1). 29–29. 44 indexed citations
8.
Xiaokaiti, Yilixiati, et al.. (2017). Direct interaction between caffeic acid phenethyl ester and human neutrophil elastase inhibits the growth and migration of PANC-1 cells. Oncology Reports. 37(5). 3019–3025. 23 indexed citations
9.
Li, Xin, Shengjun Fan, Xueyang Pan, et al.. (2016). Nordihydroguaiaretic acid impairs prostate cancer cell migration and tumor metastasis by suppressing neuropilin 1. Oncotarget. 7(52). 86225–86238. 24 indexed citations
10.
Yang, Haopeng, Shengjun Fan, Yu An, et al.. (2016). Bisdemethoxycurcumin exerts pro-apoptotic effects in human pancreatic adenocarcinoma cells through mitochondrial dysfunction and a GRP78-dependent pathway. Oncotarget. 7(50). 83641–83656. 21 indexed citations
11.
Feng, Hao, Yajun Cao, Shengjun Fan, et al.. (2015). Curcumin attenuates palmitate-induced apoptosis in MIN6 pancreatic β-cells through PI3K/Akt/FoxO1 and mitochondrial survival pathways. APOPTOSIS. 20(11). 1420–1432. 59 indexed citations
12.
Fan, Shengjun, Xin Li, Lu Tie, Yan Pan, & Xuejun Li. (2015). KIAA0101 is associated with human renal cell carcinoma proliferation and migration induced by erythropoietin. Oncotarget. 7(12). 13520–13537. 27 indexed citations
13.
Fan, Shengjun, Xu Yan, Xin Li, et al.. (2014). Opposite angiogenic outcome of curcumin against ischemia and Lewis lung cancer models: in silico, in vitro and in vivo studies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(9). 1742–1754. 39 indexed citations
14.
Li, Ji, et al.. (2014). Microarray gene expression profiling and bioinformatics analysis of premature ovarian failure in a rat model. Experimental and Molecular Pathology. 97(3). 535–541. 13 indexed citations
15.
Pan, Yan, Xin Li, Lan Yuan, et al.. (2014). Enoxaparin Sensitizes Human Non–Small-Cell Lung Carcinomas to Gefitinib by Inhibiting DOCK1 Expression, Vimentin Phosphorylation, and Akt Activation. Molecular Pharmacology. 87(3). 378–390. 24 indexed citations
17.
Tie, Lu, Yu An, Jing Han, et al.. (2012). Genistein accelerates refractory wound healing by suppressing superoxide and FoxO1/iNOS pathway in type 1 diabetes. The Journal of Nutritional Biochemistry. 24(1). 88–96. 66 indexed citations
18.
Fan, Shengjun, et al.. (2012). Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach. BMC Systems Biology. 6(1). 152–152. 28 indexed citations
19.
Fan, Shengjun & Xuejun Li. (2012). [Inverse docking--a new approach for drug targets discovery and identification].. PubMed. 43(5). 367–70. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026